← Brands in the News company

VYNE Therapeutics

Narrative intelligence for VYNE Therapeutics: 1 tracked articles, claims, and spin patterns across AI and technology coverage.

SPIN Processed Press Release Frame: The Cushion

VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics announced a special cash dividend of $0.38 per share totaling ~$16.5M ahead of its proposed merger with Yarrow Bioscience, signaling financial liquidity and shareholder return prior to consolidation.

Spin 45% Claim Present in Source

GlobeNewswire Technology

Jul 10, 2026

Related Claims

01 VYNE Therapeutics declared a special cash dividend of an estimated $16.5 million, or $0.38 per share, in connection with the proposed merger with Yarrow Bioscience.

Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO